AVON PRODUCTS INC
424B3, 2001-01-11
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Previous: ASA LTD, DEF 14A, 2001-01-11
Next: AZZ INC, 10-Q, 2001-01-11



PROSPECTUS SUPPLEMENT                           FILED PURSUANT TO RULE 424(b)(3)
To Prospectus dated December 5, 2000                  Registration No. 333-45808

                                 $840,938,000

                              AVON PRODUCTS, INC.

   Zero Coupon Convertible Senior Notes due 2020 and Shares of Common Stock
                     Issuable Upon Conversion of the Notes

                                ---------------

               This prospectus supplement relates to (1) $840,938,000
aggregate principal amount at maturity of zero coupon convertible senior notes
due 2020 of Avon Products, Inc. and (2) shares of common stock issuable upon
conversion of the notes.  This prospectus supplement will be used by the
selling securityholders listed below to resell their notes and the common
stock issuable upon conversion of their notes and we will not receive any
proceeds from sales that the selling securityholders make.

               This prospectus supplement should be read in conjunction with
the prospectus dated December 5, 2000, which is to be delivered with this
prospectus supplement.  All capitalized terms used but not defined in the
prospectus supplement shall have the meanings given them in the prospectus.

               The following table sets forth the name and number of shares
beneficially owned by selling securityholders intending to sell in connection
with this prospectus supplement the notes or common stock and the amounts of
notes or shares of common stock to be offered.  Based on information provided
to us by the applicable selling securityholder, the table also discloses
whether any selling securityholder selling in connection with this prospectus
supplement had held any position or office with, been employed by or otherwise
has had a material relationship with us or any of our affiliates during the
three years prior to the date of this prospectus supplement.

<TABLE>
<CAPTION>
                                       Principal amount
                                        at maturity of                             Number of shares
                                       notes beneficially                           of common stock    Percentage of
                                          owned that           Percentage of       that may be sold    common stock      Material
Name                                   may be sold hereby     notes outstanding       hereby (1)      outstanding (2)  relationship
----                                   ------------------     -----------------    ----------------   ---------------  ------------
<S>                                    <C>                  <C>                   <C>                 <C>              <C>
McMahan Securities Co. L.P.                $1,000,000              0.12%               8,272.30             **             None
Any other holder of notes or future
 transferee, pledgee, donee, or
 successor of any such holder(3)....       71,886,000              8.55              594,662.56             **
</TABLE>




---------------
** Less than 1%
(1) Assumes conversion of all of the holder's notes at a conversion price of
    8.2723 shares of common stock per $1,000 principal amount at maturity of
    the notes.  This conversion price, however, will be subject to adjustment
    as described under "Description of the Notes--Conversion Rights" in the
    prospectus.  As a result, the number of shares of common stock issuable
    upon conversion of the notes may increase or decrease in the future.
(2) Calculated based on Rule 13d-3(d)(1)(i) of the Exchange Act using
    238,095,339 shares of common stock outstanding as of November 22, 2000.  In
    calculating this amount, we treated as outstanding the number of shares of
    common stock issuable upon conversion of all of that particular holder's
    notes.  However, we did not assume the conversion of any other holder's
    notes.
(3) Information about other selling securityholders will be set forth in
    additional prospectus supplements, if required.  Assumes that any other
    holders of notes, or any future transferees, pledgees, donees or successors
    of or from any such other holders of notes, do not beneficially own any
    common stock other than the common stock issuable upon conversion of the
    notes at the initial conversion rate.

                                ---------------

This investment involves risk.  See "Risk Factors" beginning on page 6 of the
                                  prospectus.

 The Securities and Exchange Commission and state securities regulators have
not approved or disapproved these securities, or determined if this prospectus
 supplement is truthful or complete.  Any representation to the contrary is a
                               criminal offense.

          The date of this Prospectus Supplement is January 11, 2001


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission